IDEXX LABORATORIES INC /DE — Earnings Release 2011

Jan 28, 2011

| UNITED
STATES | | |
| --- | --- | --- |
| SECURITIES
AND EXCHANGE COMMISSION | | |
| Washington,
D.C. 20549 | | |
| FORM
8-K | | |
| CURRENT
REPORT | | |
| Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934 | | |
| Date
of report (Date of earliest event reported): January 28,
2011 | | |
| IDEXX
LABORATORIES, INC. | | |
| (Exact
name of registrant as specified in its charter) | | |
| Delaware | 000-19271 | 01-0393723 |
| (State
or other jurisdiction | (Commission
File Number) | (IRS
Employer Identification No.) |
| of
incorporation) | | |
| One
IDEXX Drive, Westbrook, Maine | 04092 | |
| (Address
of principal executive offices) | (ZIP
Code) | |
| 207.556.0300 | | |
| (Registrant's
telephone number, including area code) | | |
| Not
Applicable | | |
| (Former
name or former address, if changed since last report) | | |
| Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions (see General Instruction A.2. to Form
8-K): | | |
| o | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425) | |
| o | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) | |
| o | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) | |
| o | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) | |

Item 2.02 Results of Operations and Financial Condition.

On January 28, 2011, IDEXX Laboratories, Inc. (the “Company”) announced its financial results for the quarter and year ended December 31, 2010. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

In accordance with general instructions to Form 8-K, the information in this Form 8-K and the Exhibit 99.1 attached hereto is being furnished under Item 2.02 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed.

99.1 Press Release entitled “IDEXX Laboratories Announces Fourth Quarter and Full Year Results,” issued by the company on January 28, 2011.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| /s/
Merilee Raines |
| --- |
| Merilee
Raines |
| Corporate
Vice President and Chief
Financial Officer |

EXHIBIT INDEX

| Exhibit
No. | Description
of Exhibit |
| --- | --- |
| 99.1 | Press
Release entitled “IDEXX Laboratories Announces Fourth Quarter and Full
Year Results,” issued by the company on January 28,
2011. |